Federal Circuit’s "Philips" Ruling Key To Drug Patent Ruling

Law360, New York (August 29, 2005, 12:00 AM EDT) -- The Federal Circuit’s recent en banc ruling on claim construction in Philips v AWH Corp. provided precedent in a Markman decision earlier this month, with the court favoring a French inventor’s claim construction over that of New Jersey-based pharmaceutical company Scherer Corp.

The current suit against Scherer was brought by Dr. Laurence Paris and her Swiss licensing partner Interpharm Development SA in 2002, asserting a patent for a variation of pharmaceutical capsules without the animal byproduct gelatin.

Paris and Scherer began licensing talks on the product...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.